EXAS•benzinga•
Exact Sciences Sparks Analyst Optimism Amid Competitive Multi-Cancer Test Market
Summary
Exact Sciences' 2024 sales grew 10% to $2.76 billion, exceeding estimates. New cancer tests, including Cologuard Plus, are set for 2025 launch.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 13, 2025 by benzinga